Panel Discussion: Reviewing the Validity & Reproducibility of Preclinical Models to Quantify Fibrosis & Translate Learnings from Preclinical Research to Clinical Study
Time: 4:25 pm
day: Day One
Details:
• Determining which preclinical models are more relevant to the human pathology to confirm viable therapeutic strategies that are translatable to humans
• Evaluating to what degree new in vitro techniques are beneficial to bleomycin models
• Assess associations of drug candidate with disease severity and outcome
